Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Filip Callewaert

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com